Fintel reports that on July 25, 2025, Craig-Hallum initiated coverage of Eledon Pharmaceuticals (NasdaqCM:ELDN) with a Buy ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

During a live event, Barbara T. Ma, MD, MS, reviewed guidelines on management and best practices for the use of ...

Discover how cutting-edge tools and analytics are advancing cell therapy, improving precision, safety and scalability in ...

A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically engineered immune cells sometimes fail to finish the job when given as a cancer ...

Researchers have discovered that immune cells are the unexpected source of a protein called FAS-ligand, which has undermined ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

Around 10 million people globally live with the life-threatening virus HTLV-1, yet it remains a poorly understood disease ...

The first Saturday of May each year marks World Ankylosing Spondylitis (AS) Day, raising awareness of the 54 million patients ...

T-cell Acute Lymphoblastic Leukaemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...

DelveInsight’s, “ Small Lymphocytic Lymphoma Pipeline Insight, 2025 ” report provides comprehensive insights about 80+ ...

The FDA granted fast track status to DB-1310, a HER3-targeting antibody-drug conjugate, for advanced nonsquamous non-small ...